30 related articles for article (PubMed ID: 2702650)
1. miR-548d-3p inhibits osteosarcoma by downregulating
Chen J; Yan C; Yu H; Zhen S; Yuan Q
Aging (Albany NY); 2019 Jul; 11(14):5058-5069. PubMed ID: 31327761
[TBL] [Abstract][Full Text] [Related]
2. Twist1 promotes astrocytoma development by stimulating vasculogenic mimicry.
Cao W; Xu C; Li X; Yang X
Oncol Lett; 2019 Jul; 18(1):846-855. PubMed ID: 31289562
[TBL] [Abstract][Full Text] [Related]
3. MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1.
Liu J; Shao Y; He Y; Ning K; Cui X; Liu F; Wang Z; Li F
Cancer Sci; 2019 Jan; 110(1):135-146. PubMed ID: 30407715
[TBL] [Abstract][Full Text] [Related]
4. A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells.
Li Y; Zhang H; Zhao Y; Wang C; Cheng Z; Tang L; Gao Y; Liu F; Li J; Li Y; Li Y; Geng N; Rui X; Teng Y; Liu Y; Cao L; Kumar R; Jin F; Li F
Oncogene; 2019 Feb; 38(6):808-821. PubMed ID: 30177834
[TBL] [Abstract][Full Text] [Related]
5. PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth.
Zhang X; Zhang X; Li Y; Shao Y; Xiao J; Zhu G; Li F
Cell Death Dis; 2017 May; 8(5):e2820. PubMed ID: 28542136
[TBL] [Abstract][Full Text] [Related]
6. PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.
Zhu G; Li X; Guo B; Ke Q; Dong M; Li F
Oncogene; 2016 Apr; 35(15):1943-54. PubMed ID: 26212009
[TBL] [Abstract][Full Text] [Related]
7. By recruiting HDAC1, MORC2 suppresses p21 Waf1/Cip1 in gastric cancer.
Zhang Q; Song Y; Chen W; Wang X; Miao Z; Cao L; Li F; Wang G
Oncotarget; 2015 Jun; 6(18):16461-70. PubMed ID: 26098774
[TBL] [Abstract][Full Text] [Related]
8. PAK1-mediated MORC2 phosphorylation promotes gastric tumorigenesis.
Wang G; Song Y; Liu T; Wang C; Zhang Q; Liu F; Cai X; Miao Z; Xu H; Xu H; Cao L; Li F
Oncotarget; 2015; 6(12):9877-86. PubMed ID: 25888627
[TBL] [Abstract][Full Text] [Related]
9. Utility of Preoperative CA125 Assay in the Management Planning of Women Diagnosed with Uterine Cancer.
Povolotskaya N; Das N; Dhar K; Brinkmann D; Gardner F; Woolas R
Surg Res Pract; 2014; 2014():497478. PubMed ID: 25379556
[TBL] [Abstract][Full Text] [Related]
10. Induction of the CLOCK gene by E2-ERα signaling promotes the proliferation of breast cancer cells.
Xiao L; Chang AK; Zang MX; Bi H; Li S; Wang M; Xing X; Wu H
PLoS One; 2014; 9(5):e95878. PubMed ID: 24789043
[TBL] [Abstract][Full Text] [Related]
11. The co-expression of functional gastric proteins in dynamic gastric diseases and its clinical significance.
Xu Q; Sun LP; Wang BG; Liu JW; Li P; He CY; Yuan Y
BMC Clin Pathol; 2013 Aug; 13(1):21. PubMed ID: 23937908
[TBL] [Abstract][Full Text] [Related]
12. Expression of the c-Met Proteins in Malignant Skin Cancers.
Lee YJ; Kim DH; Lee SH; Kim DW; Nam HS; Cho MK
Ann Dermatol; 2011 Feb; 23(1):33-8. PubMed ID: 21738360
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serum CA 125 levels, endometrial thickness and corpus luteum function in different stages of ovarian activity.
Ozakşit G; Turhan NO; Oral H; Doğu N; Gökmen O
J Endocrinol Invest; 1993 Mar; 16(3):175-9. PubMed ID: 8514972
[TBL] [Abstract][Full Text] [Related]
14. Use of tumour marker immunoreactivity to identify primary site of metastatic cancer.
Gamble AR; Bell JA; Ronan JE; Pearson D; Ellis IO
BMJ; 1993 Jan; 306(6873):295-8. PubMed ID: 8461645
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential.
Berchuck A; Soisson AP; Clarke-Pearson DL; Soper JT; Boyer CM; Kinney RB; McCarty KS; Bast RC
Cancer Res; 1989 Apr; 49(8):2091-5. PubMed ID: 2702650
[TBL] [Abstract][Full Text] [Related]
16. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
Smith HO; Anderson PS; Kuo DY; Goldberg GL; DeVictoria CL; Boocock CA; Jones JG; Runowicz CD; Stanley ER; Pollard JW
Clin Cancer Res; 1995 Mar; 1(3):313-25. PubMed ID: 9815987
[TBL] [Abstract][Full Text] [Related]
17. [Preoperative levels of CA 125 and risk factors in adenocarcinoma of the endometrium].
Marcello C; Corda F; Pilloni MD; Puligheddu P; Lecca U
Ann Ostet Ginecol Med Perinat; 1989; 110(6):290-5. PubMed ID: 2639616
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.
Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614
[TBL] [Abstract][Full Text] [Related]
19. [Study on cytokeratin and CA125 for diagnosing lymph node micrometastases in endometrial cancer].
Liu FH; Wang YF; Wang J; Xue Q; Jiang S; Ma YY
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):612-5. PubMed ID: 15498190
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
